F. Benanti

1.4k total citations
11 papers, 159 citations indexed

About

F. Benanti is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, F. Benanti has authored 11 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in F. Benanti's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). F. Benanti is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). F. Benanti collaborates with scholars based in Italy and United Kingdom. F. Benanti's co-authors include Bruno Cacopardo, Giuseppe Nunnari, Wolfgang Preiser, Benedetto Maurizio Celesia, Marilia Rita Pinzone, Andrea Marıno, Federica Cosentino, Giuseppe Nunnari, Manuela Ceccarelli and Fabrizio Romano and has published in prestigious journals such as Journal of Viral Hepatitis, Infection and BMC Research Notes.

In The Last Decade

F. Benanti

11 papers receiving 153 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Benanti Italy 8 89 67 56 21 17 11 159
Elisa Biliotti Italy 9 115 1.3× 67 1.0× 102 1.8× 10 0.5× 3 0.2× 28 200
Neddie Zadeikis United States 8 144 1.6× 62 0.9× 160 2.9× 13 0.6× 7 0.4× 10 203
S. C. Arya India 8 42 0.5× 27 0.4× 68 1.2× 14 0.7× 9 0.5× 35 184
Volker Kinast Germany 9 153 1.7× 130 1.9× 54 1.0× 3 0.1× 8 0.5× 22 273
F Brun Spain 6 73 0.8× 37 0.6× 79 1.4× 4 0.2× 9 0.5× 10 147
Milotka Fabri Serbia 6 163 1.8× 48 0.7× 165 2.9× 5 0.2× 10 0.6× 27 223
Oranit Cohen‐Ezra Israel 8 109 1.2× 93 1.4× 105 1.9× 5 0.2× 20 1.2× 21 253
Le Thi Kieu Linh Vietnam 9 79 0.9× 121 1.8× 42 0.8× 2 0.1× 9 0.5× 24 191
Valeria Belvisi Italy 10 41 0.5× 78 1.2× 110 2.0× 5 0.2× 8 0.5× 20 253
Ossama Ashraf Ahmed Egypt 7 180 2.0× 23 0.3× 162 2.9× 13 0.6× 2 0.1× 27 226

Countries citing papers authored by F. Benanti

Since Specialization
Citations

This map shows the geographic impact of F. Benanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Benanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Benanti more than expected).

Fields of papers citing papers by F. Benanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Benanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Benanti. The network helps show where F. Benanti may publish in the future.

Co-authorship network of co-authors of F. Benanti

This figure shows the co-authorship network connecting the top 25 collaborators of F. Benanti. A scholar is included among the top collaborators of F. Benanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Benanti. F. Benanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Marıno, Andrea, Manuela Ceccarelli, Federica Cosentino, et al.. (2021). Immunological and Clinical Impact of DAA-Mediated HCV Eradication in a Cohort of HIV/HCV Coinfected Patients: Monocentric Italian Experience. Diagnostics. 11(12). 2336–2336. 19 indexed citations
2.
Marıno, Andrea, Federica Cosentino, Manuela Ceccarelli, et al.. (2021). Entecavir resistance in a patient with treatment‑naïve HBV: A case report. Molecular and Clinical Oncology. 14(6). 113–113. 17 indexed citations
3.
Marıno, Andrea, Federica Cosentino, Manuela Ceccarelli, et al.. (2020). Modification of Serum Brain-Derived Neurotrophic Factor Levels Following Anti-HCV Therapy with Direct Antiviral Agents: A New Marker of Neurocognitive Disorders. Hepatitis Monthly. 20(2). 6 indexed citations
4.
Zanghì, Antonio, et al.. (2014). Cirrhotic patients are still at risk of developing hepatocellular carcinoma despite Interferon-induced sustained virological response.. PubMed. 18(2 Suppl). 11–5. 11 indexed citations
5.
Cacopardo, Bruno, F. Benanti, Marilia Rita Pinzone, & Giuseppe Nunnari. (2013). Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature. BMC Research Notes. 6(1). 437–437. 21 indexed citations
6.
Nunnari, G., Benedetto Maurizio Celesia, Simona Tosto, et al.. (2010). Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect.. PubMed. 14(12). 1015–8. 16 indexed citations
7.
8.
Cacopardo, Bruno, et al.. (2004). Fatal hepatitis during Epstein-Barr virus reactivation.. PubMed. 7(4). 107–9. 13 indexed citations
9.
Cacopardo, Bruno, et al.. (1998). Leucocyte interferon‐α retreatment for chronic hepatitis C patients previously intolerant to other interferons. Journal of Viral Hepatitis. 5(5). 333–339. 16 indexed citations
10.
Cacopardo, Bruno, et al.. (1997). Acute hepatitis E in catania (eastern sicily) 1980–1994. The role of hepatitis E virus. Infection. 25(5). 313–316. 36 indexed citations
11.
Cacopardo, Bruno, et al.. (1995). [Long-term study of anti-HCV reactivity using 3d generation recombinant immunoblot assay in acute post-transfusion hepatitis].. PubMed. 86(10). 378–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026